In our work we analyzed utilisation of antibiotics for systemic use at the Surgical Clinic of the Clinical Hospital Centre - Pristina in Gracanica in 2007. and 2008. Data on antibiotic utilization were delivered on the basis of drug dispensing records from the Central Hospital Pharmacy during the two-years period. Antibiotics were distributed inside the ATC/DDD system in accordance with WHO guidelines. Quantitative antibiotics' utilisation was expressed as number of defined daily doses per 100 patient-days (DDDs/100 PD). Overall use of antibiotics in 2007 was 123.37 DDDs/100 PD, and 125.09 DDDs /100 PD in 2008. Three most utilized antibiotics in 2007. were cefuroxime 24.26 DDDs/100 PD (19.66 % of total antibiotics' use), ceftriaxone 16.65 DDDs/100 PD (13.49 %), and cephalexin 15.78 DDDs/100 PD (12.79 %). In 2008. the most utilized were ceftriaxone 23.23 DDDs/100 PD (18.57 %), cefuroxime 22.53 DDDs/100 PD (18.01 %), and co-trimoxazole 19,55 DDDs/100 PD (15.63 %). Qualitative and quantitative part of the consumed antibiotics was mainly in accordance with the results of similar researches in our country.
Verburgh HA. Mapping antibiotic use and resistance in the Netherlands: SWAB and NethMap. Neth J Med. 61:341–2.
2.
Song F, Glenny AM. Antimicrobial prophylaxis in colorectal surgery: A systematic review of randomized controlled trials. Br J Surg. 85(9):1232–41.
3.
In: Oxford Handbook of Clinical Medicine.
4.
Blumer J. Pharmacokinetics of ceftriaxone. 5:7–13.
5.
Pešić G, Jović Z, Vasić K. Analiza upotrebe antimikrobnih lekova primenom ATC/DDD metodologije na dve Univerzitetske hirurške klinike. Facta universitatis-series: Medicine and Biology. 12(3):174–8.
6.
A TA, Hrvatskoj. In PPMP, izvještaj ESAC. Akademija medicinskih znanosti Hrvatske, Kolegij javnog zdravstva, Odbor za praćenje rezistencije bakterija na antibiotike u Republici Hrvatskoj. In: F Mihaljević”, Referentni centar za praćenje rezistencije bakterija na antibiotike Ministarstva zdravstva i socijalne skrbi RH.
7.
Radonjić V, Lj D, Stefanović D, Tešić D. Promet i potrošnja antibiotika u Republici Srbiji. Arh Farm. 57:332–46.
8.
Veličković-Radovanović R, Petrović J, Kočić B, Antić S, Ranđelović G. Correlation between antibiotic consumption and bacterial resistance as a quality indicator of proper use of these drugs in inpatients. Vojnosanit Pregl. 66(4):307–12.
9.
Divac N, Stevanović G, Pelemis M, Prostran M. Article title. Int J Antimicrob Agents. 2(53).
10.
Drug consumption in Norway.
11.
European Surveillance of Antimicrobial Consumption.
12.
Fridkin SK, Steward CD, Edwards. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Clin Infect Dis. 29:245–52.
13.
With K, J B, J B. Antibiotic use in German university hospitals 1998-2000 (project INTERUNI-II. Int J Antimicrob Agents. 24:15–20.
14.
Bager F. DANMAP: Monitoring antibiotic use and resistance in Denmark. Int J Antimicrob Agents. 14:271–4.
15.
World Health Organization.
16.
Berild D. Is it possible to influence the utilization of antibiotics? Tidsskr Nor Laegeforen. 117(14):256–9.
17.
Kunin CM, Staehr Johansen K, Worning AM, Dascher F. Report of a symposium on use and abuse of antibiotics worldwide. Rev Infect Dis. 12:12–9.
18.
Filius PMG, Liem TBY, Linden PD, Janknegt R, Natsch S, Vulto AG. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother. 55:805–8.
19.
Gold HS, Moellering RC. Antimicrobial drug resistance. N Engl J Med. 335:1445–53.
20.
Kritsotakis EI, Gikas A. Surveillance of antibiotic use in hospitals: Methods, trends and targets. Clin Microbiol Infect. 12:701–4.
21.
Smith AJ, Aronson JK, Thomas M. Antibiotics policies in the developing world. Eur J Clin Pharmacol. 41:85–7.
22.
WHO Collaborating Centre for Drug Statistic Methodology. ATC classification index with DDDs 2008.
23.
ATC klasifikacija lekova sa definisanim dnevnim dozama za LEKOVE U PROMETU.
24.
lekova N. Agencija za lekove i medicinska sredstva Srbije.
25.
WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistic Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. In: Introduction to drug utilization research.
26.
WHO Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC classification and DDD assignment.
27.
Bergman U. The history of the Drug Utilization Research Group in Europe. Pharmacoepidemiol Drug Saf. 15(2):95–8.
28.
Djaković-Švajcer K, Krajniker-Kiš V, Jakovljević V. Upotreba lekova u ambulantnom lečenju na teritoriji Sremske Mitrovice. In: Farmakoepidemiologija: Proučavanje upotrebe lekova sa ATC klasifikacijom Srpsko lekarsko društvo - Podružnica Priština. p. 43–51.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
